Apeloa is a pharmaceutical company headquartered in Jinhua, China, providing global CRDMO, generic API, and drug product solutions to clients. Listed on the Shenzhen stock exchange, Apeloa provides small molecule support from discovery to commercialization with flow chemistry, fermentation, crystallization, and HPAPI capabilities. Founded in 1989, they are consistently ranked among the top Chinese CDMOs and API exporters and have a second facility in Waltham, Massachusetts.
Visit Company Website
